VC  Hamilton Square Partners Management

https://hsqhealthcare.com/





     Office Locations:

300 Carnegie Center, Suite 150
Princeton, NJ 08544
Phone: 212-679-1786

 
Stages:

  • Early


 
Industries:

  • Life Sciences & Healthcare

  •  
    Description:

    Founded in 2025, Hamilton Square Partners Management is a private equity firm based in Princeton, New Jersey investing in healthcare innovation.


     
    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     
    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    David Tukey Chief Investment Officer
    James Campion COO
    Joe Battaglia Senior Analyst & Managing Director

     
    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/18/2026


      Crossbow Therapeutics


      MA


      $77,000,000


      Series B


     
    Portfolio companies include:

     
    Recent News: